AQUA Laminoplasty Systems
by ZheJiang Decans Medical Devices Co., Ltd.
510(k) K252930
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK252930 | Date27 May 2026 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NQW
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3050
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The AQUA Laminoplasty Systems is a metal orthopedic device classified as a spine plate for laminoplasty procedures. It is designed to stabilize and support cervical vertebrae during surgical reconstruction, facilitating decompression of the spinal cord and nerve roots by maintaining proper spinal alignment and spacing. Constructed from biocompatible metal, it is intended for use in spinal fusion surgeries where laminoplasty techniques are applied to address spinal stenosis or other degenerative conditions.
These systems are supplied sterile and intended for single-use, adhering to FDA-regulated standards under classification NQW and regulation 888.3050. They are used in operating room settings by orthopedic surgeons and are compatible with standard surgical imaging. The device is authorized for marketing via FDA 510(k) clearance (K252930), determined to be substantially equivalent to predicate devices. Multiple reference codes (e.g., 3000270450, 3003935342) correspond to specific model variants, ensuring traceability and regulatory compliance.
Other devices from ZheJiang Decans Medical Devices Co., Ltd.
See all devices from ZheJiang Decans Medical Devices Co., Ltd. →
Questions
AI-generated answers, 1 Oct 2026
What is the AQUA Laminoplasty Systems used for in spinal surgery?
The AQUA Laminoplasty Systems is designed for laminoplasty procedures in cervical spine surgery. It stabilizes and supports vertebrae to maintain proper alignment and spacing, which helps decompress the spinal cord and nerve roots. This is particularly useful for addressing spinal stenosis or degenerative conditions where surgical reconstruction is required.
How is the AQUA Laminoplasty Systems supplied, and what does this mean for clinical use?
The AQUA Laminoplasty Systems is supplied sterile, ensuring it is ready for immediate use in the operating room without additional sterilization steps. This sterile packaging adheres to FDA-regulated standards, reducing the risk of infection and ensuring compliance with surgical protocols. The single-use nature of the device also minimizes cross-contamination risks between patients.
Are there different models or reference codes for the AQUA Laminoplasty Systems, and why does this matter?
Yes, the AQUA Laminoplasty Systems includes multiple reference codes (e.g., 3000270450, 3003935342) corresponding to specific model variants. These codes ensure traceability and regulatory compliance, allowing clinicians and institutions to identify the exact variant used in a procedure. This is critical for inventory management, recall tracking, and maintaining adherence to FDA guidelines.
How should the AQUA Laminoplasty Systems be stored before use?
While the exact storage instructions are not detailed in the provided data, sterile medical devices like the AQUA Laminoplasty Systems are typically stored in a clean, dry environment protected from moisture, dust, and extreme temperatures. The sterile packaging should remain intact until immediately before use to preserve sterility. Always follow the manufacturer’s specific storage guidelines, which may be included in the accompanying documentation.
What regulatory pathway does the AQUA Laminoplasty Systems follow, and what does this mean for clinicians?
The AQUA Laminoplasty Systems is authorized for marketing via FDA 510(k) clearance (K252930), determined to be substantially equivalent to predicate devices. This means the device has undergone rigorous review by the FDA to ensure it meets safety and effectiveness standards for its intended use in laminoplasty procedures. Clinicians can rely on this clearance as evidence of the device’s regulatory compliance and suitability for spinal fusion surgeries.